News & Press: Breaking News

Survey of Cellular and Engineered Tissue Therapies in Europe - Patients Treated in 2013

Friday, December 5, 2014   (0 Comments)
Posted by: ISCT Administrator
Share |

Dear colleagues,

We are collecting data in order to establish a comprehensive, quantitative map of patients being treated in Europe with novel cellular therapies (i.e. any clinical treatment based on living cells excluding donor lymphocyte infusions – DLI – and hematopoietic stem cells for haematological reconstitution). The survey is supported by ISCT, EBMT, TERMIS, EULAR, ICRS, and IFATS and integrates the original EBMT activity survey capturing hematopoietic stem cells transplants in Europe.
Enclosed below is a file of the survey reports published in the last 3 years, including the number of treated patients, without any reference to clinical outcomes, as well as information on specific cell types, processes and delivery modes in use.

If, in 2013, you treated patients in Europe with novel cellular therapies and would like to see your name listed among the participating teams (138 groups in 2012), please complete the enclosed survey form and send it to Helen Baldomero in the Activity Survey Office by December 31st 2014, by Email: or by fax: + 41 61 265 2735

If you know of any team that is performing such therapies, please forward this message to them and encourage them to participate. This will help to bring an effective impact on the scientific, clinical and regulatory aspects of the quickly evolving sector of novel cellular therapies.

Thank you and with our best regards,
Prof. Ivan Martin PhD
Depts. of Surgery and Biomedicine
University Hospital Basel, CH

Prof. Jakob R Passweg MD
Chief Hematology Clinic and
EBMT Transplant Activity Survey Office
University Hospital Basel, CH


Survey from 2013 patients

Letter to Members re Survey for 2013 Patients

Guidelines for reporting data

Publications: Cellular and engineered tissue therapy survey 2010-2012

© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.